Breaking News Instant updates and real-time market news.

DBVT

DBV Technologies

$9.45

0.75 (8.62%)

07:23
07/05/19
07/05
07:23
07/05/19
07:23

DBV rallies on expectations of peanut allergy submission, Bloomberg reports

DBV Technologies shares are rallying today amid expectations that the company will submit another biologic license application for its Viaskin Peanuts allergy patch to the FDA sometime during the third quarter, Konrad Krasuski of Bloomberg reports. Shares of DBV are up 25%, or $2.41, to $11.85 in premarket trading. Analyst Martial Descoutures of Oddo Bhf told Bloomberg in an email, "We expect a re-filing of Viaskin Peanuts in the U.S. in the next days or weeks, after company confirmed that they would like to submit a fresh application in the 3Q."

DBVT DBV Technologies
$9.45

0.75 (8.62%)

04/10/19
STFL
04/10/19
NO CHANGE
STFL
Hold
ICER draft report presents modest headwind for DBV, Aimmune, says Stifel
Stifel analyst Derek Archila noted that ICER, an independent and non-partisan research organization that analyzes the benefits along with costs of treatments, issued a draft report assessing the value and effectiveness of Aimmune's (AIMT) AR101 and DBV Technologies' (DBVT) Viaskin peanut for peanut allergy. He believes ICER's cost-effectiveness analysis re-affirms his cautious approach on the peanut immunotherapy category and believes the report presents a modest headwind for the stocks. However, this was only a draft report in which ICER made assumptions for costs since no official pricing has been announced for either therapy, Archlia noted. He maintains Hold ratings on both Aimmune and DBV Technologies.
05/20/19
FBCO
05/20/19
INITIATION
Target $30
FBCO
Outperform
Aimmune assumed with an Outperform at Credit Suisse
Credit Suisse analyst Evan Seigerman assumed coverage of Aimmune Therapeutics (AIMT) with an Outperform rating and lowered the price target on the stock to $30 from the firm's prior $36 target, citing his belief that AR101 is likely to be approved to reduce risk from exposure in children and adults with peanut allergy. Aimmune's only competitor in peanut allergy treatment, DBV Therapeutics (DBVT), is at least a year behind in his view, Seigerman tells investors.Target $30.
06/17/19
GSCO
06/17/19
INITIATION
Target $14
GSCO
Buy
DBV Technologies initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Graig Suvannavejh started DBV Technologies (DBVT) with a Buy rating and $14 price target. DBVT is a late-stage specialty biotech company, with a proprietary technology platform that could be used to treat a range of food allergies, Suvannavejh tells investors in a research note. The analyst sees 66% upside from current share levels given the potential catalysts over the next 18 months, which include the Biologics License Applications re-filing in Q3 and FDA acceptance in Q4, a potential panel hearing in mid-2020, and likely final U.S. approval by the end of 2020. Suvannavejh sees an 85% probability of success for DBV's Viaskin Peanut and views the treatment as a more compelling option versus Aimmune's (AIMT) AR101 on overall safety and product presentation profiles.
06/17/19
06/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DBV Technologies (DBVT) initiated with a Buy at Goldman Sachs. 2. Amicus (FOLD) initiated with a Buy at H.C. Wainwright. 3. Viper Energy (VNOM) initiated with a Buy at SunTrust. 4. GNC Holdings (GNC) initiated with a Hold at Jefferies. 5. Eventbrite (EB) initiated with an Outperform at William Blair. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

CACI

CACI

$216.89

0.91 (0.42%)

17:30
09/17/19
09/17
17:30
09/17/19
17:30
Upgrade
CACI rating change  »

CACI added to Conviction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

ANF

Abercrombie & Fitch

$16.25

0.08 (0.49%)

17:29
09/17/19
09/17
17:29
09/17/19
17:29
Initiation
Abercrombie & Fitch initiated  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

FB

Facebook

$188.13

1.89 (1.01%)

, GOOG

Alphabet

$1,229.61

-1.75 (-0.14%)

17:28
09/17/19
09/17
17:28
09/17/19
17:28
Periodicals
U.S. antitrust regulators admit to 'squabbles' amid Big Tech probe, Reuters says »

U.S. regulators concede…

FB

Facebook

$188.13

1.89 (1.01%)

GOOG

Alphabet

$1,229.61

-1.75 (-0.14%)

AMZN

Amazon.com

$1,822.59

14.38 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Oct

T

AT&T

$37.16

-0.16 (-0.43%)

17:25
09/17/19
09/17
17:25
09/17/19
17:25
Hot Stocks
AT&T sees wireless service revenue growth continuing in second half of 2019 »

Randall Stephenson,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CDW

CDW

$113.91

0.94 (0.83%)

, TSS

TSYS

$132.86

-1.7 (-1.26%)

17:17
09/17/19
09/17
17:17
09/17/19
17:17
Hot Stocks
CDW to replace TSYS in S&P 500 at open on 9/23 »

Global Payments (GPN) is…

CDW

CDW

$113.91

0.94 (0.83%)

TSS

TSYS

$132.86

-1.7 (-1.26%)

GPN

Global Payments

$163.91

-2.21 (-1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 13

    Nov

STBA

S&T Bancorp

$37.22

-0.17 (-0.45%)

17:16
09/17/19
09/17
17:16
09/17/19
17:16
Hot Stocks
S&T Bancorp board authorizes new $50M stock buyback »

The board of S&T…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$173.53

-0.14 (-0.08%)

17:12
09/17/19
09/17
17:12
09/17/19
17:12
Downgrade
FedEx rating change  »

FedEx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 13

    Nov

NEXT

NextDecade

$6.30

-0.1 (-1.56%)

17:10
09/17/19
09/17
17:10
09/17/19
17:10
Initiation
NextDecade initiated  »

NextDecade initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$8.33

-0.1 (-1.19%)

17:10
09/17/19
09/17
17:10
09/17/19
17:10
Initiation
Tellurian initiated  »

Tellurian initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLNK

NewLink Genetics

$1.90

-0.03 (-1.55%)

, MRK

Merck

$82.53

0.52 (0.63%)

17:06
09/17/19
09/17
17:06
09/17/19
17:06
Hot Stocks
NewLink Genetics says FDA accepts partnered BLA for ebola vaccine »

NewLink Genetics…

NLNK

NewLink Genetics

$1.90

-0.03 (-1.55%)

MRK

Merck

$82.53

0.52 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 20

    Sep

  • 24

    Sep

  • 27

    Sep

  • 02

    Oct

  • 03

    Oct

  • 29

    Oct

ESTC

Elastic

$93.80

2.15 (2.35%)

17:03
09/17/19
09/17
17:03
09/17/19
17:03
Hot Stocks
Elastic selected by New Zealands'The Warehouse for its customer service program »

Elastic N.V. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

TOL

Toll Brothers

$40.68

-0.11 (-0.27%)

17:00
09/17/19
09/17
17:00
09/17/19
17:00
Hot Stocks
Toll Brothers CEO sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTR

Aqua America

$43.88

0.51 (1.18%)

16:56
09/17/19
09/17
16:56
09/17/19
16:56
Hot Stocks
Aqua America subsidiary to buy municipal wastewater system for $276.5M »

Aqua America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$28.49

0.31 (1.10%)

16:54
09/17/19
09/17
16:54
09/17/19
16:54
Syndicate
Invitation Homes files to sell 44M shares of common stock for holders »

Morgan Stanley, Citigroup…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MODN

Model N

$28.43

0.275 (0.98%)

, IQV

Iqvia

$152.93

2.14 (1.42%)

16:49
09/17/19
09/17
16:49
09/17/19
16:49
Hot Stocks
Model N names Suresh Kannan as Chief Product Officer »

Model N (MODN) announced…

MODN

Model N

$28.43

0.275 (0.98%)

IQV

Iqvia

$152.93

2.14 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 08

    Oct

  • 12

    Nov

GWW

Grainger

$291.76

-4.29 (-1.45%)

16:49
09/17/19
09/17
16:49
09/17/19
16:49
Conference/Events
Grainger management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 23

    Oct

ACGL

Arch Capital

$40.89

0.33 (0.81%)

16:48
09/17/19
09/17
16:48
09/17/19
16:48
Conference/Events
Arch Capital management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

TOL

Toll Brothers

$40.68

-0.11 (-0.27%)

16:47
09/17/19
09/17
16:47
09/17/19
16:47
Hot Stocks
Toll Brothers president Hartman sells over 40,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$28.56

0.31 (1.10%)

16:45
09/17/19
09/17
16:45
09/17/19
16:45
Hot Stocks
VA Partners reports 8.8% stake in KKR »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

ADBE

Adobe

$284.59

1.54 (0.54%)

16:44
09/17/19
09/17
16:44
09/17/19
16:44
Hot Stocks
Adobe down 3.5% at $274.65/share after reducing Digital Experience bookings view »

Shares of Adobe are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Sep

  • 23

    Oct

  • 27

    Oct

16:41
09/17/19
09/17
16:41
09/17/19
16:41
General News
API crude inventories for week of September 13 »

API reports that crude…

CAL

Caleres

$22.08

-0.71 (-3.12%)

16:35
09/17/19
09/17
16:35
09/17/19
16:35
Hot Stocks
Caleres appoints Angela Bass as Chief Human Resources Officer »

Caleres announced Angela…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 02

    Oct

CHSP

Chesapeake Lodging

$27.20

-0.2 (-0.73%)

, PK

Park Hotels & Resorts

$25.80

-0.32 (-1.23%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Hot Stocks
Chesapeake Lodging completes sale of two new York hotels for $138M »

Chesapeake Lodging Trust…

CHSP

Chesapeake Lodging

$27.20

-0.2 (-0.73%)

PK

Park Hotels & Resorts

$25.80

-0.32 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAE

CAE

$25.54

0.4 (1.59%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Conference/Events
CAE management to meet with CIBC »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 13

    Nov

UNVR

Univar

$22.68

0.29 (1.30%)

16:34
09/17/19
09/17
16:34
09/17/19
16:34
Hot Stocks
Univar selected as distributor for Unovyn's chlorinated paraffins in U.S. »

Univar Solutions has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.